Market Research Logo

Antidepressant Market in the US 2015-2019

Antidepressant Market in the US 2015-2019

About Depression

According to the WHO, depression is a common mental disorder which contributes significantly to the global burden of disease. It affects people across communities in the world. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration, as stated by the WHO. Depression can roughly be categorized into six different types. A patient with severe depression can have suicidal thoughts or behaviors. According to a 2012 WHO estimate, approximately 3,000 suicides take place each day, resulting in more than a million deaths per annum. Depression can be recurrent, and can be severely debilitating for an individual. In patients with mild depression, the patient can be treated with medications, and in moderate or severe depression, a patient needs both medication and professional psychotherapy in terms of counseling. It has been reported by the WHO in 2008, that depression equally affects men and women, but women have a 50 percent higher tendency to get affected by depression than men. According to the CDC, depression can lead to adverse behavioral traits in an individual such as, alcoholism, smoking, and sleep disturbance. According to the CDC factsheet, one out of every 10 people is affected with depression in the US. Major depressive disorder is among the most debilitating disorders in the US, and affects approximately 14.8 million adults in the country, aged 18 years and above, according to the NIMH in the US.

TechNavio's analysts forecast the Antidepressant market in the US to grow at a CAGR of [4.08] percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Antidepressant market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of depression. The Antidepressant market in the US is segmented based on the mechanism of action of the drugs used to treat depression, as illustrated below:

  • Tricyclic Antidepressants
  • Serotonin Norepinephrine Reuptake Inhibitors
  • Selective Serotonin Reuptake Inhibitors
  • Monoamine Oxidase Inhibitors
  • Others
The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the Antidepressant market in the US. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, Antidepressant Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the landscape of the Antidepressant market in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors
  • Actavis
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Otsuka Pharmaceutical
  • Pfizer
Other Prominent Vendors
  • Abbott Laboratories
  • AstraZeneca
  • Aurobindo Pharma
  • Bristol-Myers Squibb
  • Dr. Reddy's Laboratories
  • H. Lundbeck
  • Janssen Pharmaceuticals
  • Lupin
  • Novartis
  • Pierre Fabre
  • Shire
  • Somerset Pharmaceuticals
  • Sun Pharmaceutical
  • Sunovion Pharmaceuticals
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
  • Torrent Pharmaceuticals
  • Valeant Pharmaceuticals
Market Driver
  • Rise in Patient Population
  • For a full, detailed list, view our report
Market Challenge
  • Threat from Patent Expiries
  • For a full, detailed list, view our report
Market Trend
  • Growing Public Awareness
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

TechNavio Announces the Publication of its Research Report – Antidepressant Market in the US 2015-2019

TechNavio recognizes the following companies as the key players in the Antidepressant Market in the US: Actavis plc, Eli Lilly and Co., GlaxoSmithKline plc, Otsuka Pharmaceutical Co. Ltd. and Pfizer Inc.

Other Prominent Vendors in the market are: Abbott Laboratories, Astrazeneca, Aurobindo Pharma, Bristol-Myers Squibb, Dr. Reddy's Laboratories, H. Lundbeck, Janssen Pharmaceuticals, Lupin, Novartis, Pierre Fabre, Shire, Somerset Pharmaceuticals, Sun Pharmaceutical, Sunovion Pharmaceuticals, Takeda Pharmaceutical, Teva Pharmaceutical, Torrent Pharmaceuticals and Valeant Pharmaceuticals.

Commenting on the report, an analyst from TechNavio’s team said: “Increased awareness of depression among the medical community, patients, and the families of patients is one major trend in this market. This can result in an increase in the number of treatment-seeking patients, which in turn can result in an increase in the overall consumption of medicines.”

According to the report, an increase in patient population and changes in lifestyles are major factors propelling the growth of the market. Current treatment options do not provide a cure for the disorder, hence, there is a significant unmet need in the market. Therefore, drugs that can cause remission of depression in patients are expected to drive the growth of the market.

Further, the report states that one of the major challenges in the market is the expiry of the patents of major branded drugs, which is expected to lead to the erosion of their market share and a fall in the revenue generated by them. This is also expected to impact the size of the Antidepressant market in the US.

Companies Mentioned

Actavis , Eli Lilly and Company, GlaxoSmithKline , Otsuka Pharmaceutical , Pfizer , Abbott Laboratories, AstraZeneca, Aurobindo Pharma, Bristol-Myers Squibb, Dr. Reddy's Laboratories, H. Lundbeck, Janssen Pharmaceuticals, Lupin, Novartis, Pierre Fabre , Shire , SomersetPharmaceuticals, Sun Pharmaceutical, Sunovion Pharmaceuticals, Takeda Pharmaceutical, Teva Pharmaceutical, Torrent Pharmaceuticals, Valeant Pharmaceuticals

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Product Profiles
    • Celexa
      • Fetzima
      • Lexapro
      • Viibryd
      • Cymbalta
      • Prozac
      • Symbyax
      • Paxil
      • Wellbutrin
      • Abilify
      • Effexor
      • Pristiq
      • Zoloft
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Disorder Overview
    • Types of Depression
      • Table NIMH Classification of Depression
      • Major Depressive Disorder
      • Persistent Depressive Disorder
      • Psychotic Depression
      • Postpartum Depression
      • Seasonal Affective Disorder
      • Bipolar Disorder
    • Etiology
    • Epidemiology
      • Bipolar Disorder among Adults
        • Table Prevalence Data for Major Depressive Disorder among Adults in US (2012)
      • Dysthymic Disorder among Adults
        • Table Prevalence Data for Dysthymic Disorder among Adults in US (2012)
      • Major Depression among Adults
        • Table Prevalence Data for Major Depressive Disorder with Severe Impairment among Adults in US (2012)
        • Table Prevalence Data for Major Depressive Disorder among Adults in US (2012)
      • Major Depression among Adolescents
        • Table Prevalence Data for Major Depression among Adults in US (2012)
    • Treatment and Management
      • Table WHO Guidelines for Management of Depression
    • Economic Burden
      • Table Economic Burden of Depression in US
      • Table Segmentation of Costs Associated with Depression
      • Table Snapshot of Economic Burden of Depression in US
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Antidepressant Market in US 2014-2019 (US$ million)
      • Table Drivers and Challenges of Antidepressant Market in US
    • Five Forces Analysis
  • Market Segmentation by Mechanism of Action
    • Table Segmentation of Antidepressant Market in US by Mechanism of Action
    • Table Segmentation of Antidepressants Market in US by Mechanism of Action
  • Buying Criteria
    • Table Buying Criteria of Antidepressant Market in US
  • Market Growth Drivers
  • Drivers and their Impact
    • Table Drivers and their Impact on Key Customer Categories
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • Table Market Share Analysis of Antidepressant Market in US 2014
      • Competitive Assessment of Top Drugs Used for Treating Depression
        • Table Revenue Comparison of Top Drugs Used for Treating Depression in 2013 (US$ million)
      • Eli Lilly
        • Table YoY Revenue of Cymbalta in US 2010-2013 (US$ million)
        • Table YoY Global Revenue of Cymbalta 2010-2013 (US$ million)
      • Otsuka Pharmaceutical
        • Table YoY Global Revenue of Abilify 2010-2013 (US$ million)
      • Pfizer
        • Table YoY Global Revenue of Pristiq 2010-2014 (US$ million)
        • Table YoY Global Revenue of Zoloft 2010-2014(US$ million)
        • Table YoY Global Revenue of Effexor 2010-2014(US$ million)
      • GlaxoSmithKline
        • Table YoY Revenue of Wellbutrin in US 2010-2013 (US$ million)
        • Table YoY Global Revenue of Wellbutrin 2010-2013 (US$ million)
        • Table YoY Global Revenue of Paxil 2010-2014 (US$ million)
      • Actavis
    • Other Prominent Vendors
  • Key Vendor Analysis
    • Actavis
      • Key Facts
      • Business Description
      • Business Segmentation
        • Table Global Military Laser Systems Market 2015-2019Business Segmentation 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Small Arms Market in the US 2015-2019 Business Segmentation by Revenue 2012 and 2013 (US$ million)
      • Sales by Geography
        • Table Actavis : Sales by Geography (in US$ million)
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Eli Lilly
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue
        • Table Eli Lilly: Business Segmentation by Revenue 2013
        • Table Eli Lilly: Business Segmentation by Revenue 2012 and 2013 (US$ million)
      • Sales by Geography
        • Table Eli Lilly: Sales by Geography 2013
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • GlaxoSmithKline
      • Key Facts
      • Business Overview
      • Business Segmentation
        • Table GlaxoSmithKline: Business Segmentation 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
      • Sales by Geography
        • Table GlaxoSmithKline: Sales by Geography 2013
      • Pipeline Products
        • Table GlaxoSmithKline: Pipeline Products 2013
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Otsuka Pharmaceutical
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table Otsuka Pharmaceutical: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table Otsuka Pharmaceutical: Business Segmentation by Revenue 2013 and 2014 (US$ million)
      • Geographical Segmentation by Revenue 2014
        • Table Otsuka Pharmaceutical: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Pfizer
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Pfizer: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Pfizer: Business Segmentation by Revenue 2012 and 2013
      • Geographical Segmentation by Revenue
        • Table Pfizer: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report